Leading the way to safer medication
 Crosscheck  Recommender

Alogliptin

Description

Alogliptin is a potent and highly selective inhibitor of DPP-4, >10,000-fold more selective for DPP-4 than other related enzymes including DPP-8 and DPP-9. Alogliptin improves glycaemic control via a glucose-dependent mechanism, whereby insulin release is enhanced and glucagon levels are suppressed when glucose levels are high.

Medicine classification

ATC Code
Title
Class
A10BH04
Alogliptin
A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors

Medicines

Drug
Countries

Australia Canada Singapore United States

Austria Lithuania Spain United Kingdom

Other medications with this active ingredient in combination: INCRESYNC KAZANO NESINA MET OSENI VIPDOMET

Product monographs

Monograph
Type
Country
VIPIDIA Film-coated tablets
MPI, EU: SmPC
NESINA Film-coated tablet
MPI, US: SPL/PLR
US